Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D4AGB6
|
|||
| Drug Name |
Voyager-V1
|
|||
| Synonyms |
VSV-IFNBeta-NIS
Click to Show/Hide
|
|||
| Drug Type |
Oncolytic virus therapy
|
|||
| Indication | Hepatocellular carcinoma [ICD-11: 2C12.02; ICD-10: C22.0; ICD-9: 155] | Phase 2 | [1] | |
| Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 2 | [1] | ||
| Non-small-cell lung cancer [ICD-11: 2C25] | Phase 2 | [1] | ||
| Company |
Vyriad
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04291105) Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.